Literature DB >> 6921201

Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.

C A Smith, C W Vogel, H J Müller-Eberhard.   

Abstract

The molecular architecture of the cobra venom factor (CVF)-dependent C3/C5 convertase (EC 3.4.21.47) of human complement was deduced from electron microscopy of the purified bimolecular complex (CVF,Bb) and its isolated subunits, CVF and Bb. Negatively stained CVF imaged as an irregularly shaped cylindrical structure, with approximate dimensions of 137 A x 82 A (length x diameter). The zymogen Factor B appeared globular with a diameter of about 80 A and its image suggested a bipartite structure of two compact, closely associated regions, one about twice as large as the other. Bb, the larger, catalytic site-bearing cleavage fragment of Factor B, revealed two globular domains, each 40 A in diameter, connected by a short linker region about 10 A long and thick. CVF and Bb could be distinguished in micrographs of the CVF,Bb complex: Bb attached to one end of the CVF molecule through only one of its two domains, and in an orientation making the long axes of both molecules approximately orthogonal. It is suggested the naturally occurring C3 convertases (C3b,Bb and C4b,2a) have a similar morphology.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6921201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.

Authors:  H Jing; Y Xu; M Carson; D Moore; K J Macon; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.

Authors:  Bert J C Janssen; Lucio Gomes; Roman I Koning; Dmitri I Svergun; Abraham J Koster; David C Fritzinger; Carl-Wilhelm Vogel; Piet Gros
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

3.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 4.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 5.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

6.  The principal site of glycation of human complement factor B.

Authors:  M A Niemann; A S Bhown; E J Miller
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

7.  Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b.

Authors:  B Dahlbäck; C A Smith; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.

Authors:  Marisol A Figueira; Sanjay Ram; Richard Goldstein; Derek W Hood; E Richard Moxon; Stephen I Pelton
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

9.  MHC Class III products: an electron microscopic study of the C3 convertases of human complement.

Authors:  C A Smith; C W Vogel; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Authors:  Anna Schubart; Karen Anderson; Nello Mainolfi; Holger Sellner; Takeru Ehara; Christopher M Adams; Aengus Mac Sweeney; Sha-Mei Liao; Maura Crowley; Amanda Littlewood-Evans; Sophie Sarret; Grazyna Wieczorek; Ludovic Perrot; Valérie Dubost; Thierry Flandre; Yuzhou Zhang; Richard J H Smith; Antonio M Risitano; Rajeshri G Karki; Chun Zhang; Eric Valeur; Finton Sirockin; Bernd Gerhartz; Paulus Erbel; Nicola Hughes; Thomas M Smith; Frederic Cumin; Upendra A Argikar; Börje Haraldsson; Muneto Mogi; Richard Sedrani; Christian Wiesmann; Bruce Jaffee; Jürgen Maibaum; Stefanie Flohr; Richard Harrison; Jörg Eder
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.